Spotlight
Clinical Role
Clinical
Supplement Spotlight
CE
Subscribe
Tara Esse, PharmD, BCACP
Articles
Medicare Part D Insulin Tiering Change: Impact on Health Outcomes
Alexander T. Nguyen, PharmD;Ruta V. Sawant, MS;Omar Serna, PharmD, BCACP;Tara Esse, PharmD, BCACP;Sujit S. Sansgiry, PhD
October 19th 2016This study explores the impact of a Medicare Part D formulary tier change, specifically with respect to branded insulin products, on insulin adherence, hemoglobin A1C, and diabetes-related events in elderly diabetic beneficiaries strategies for selection of appropriate and cost-effective therapy will also be discussed.
Read More
Latest Updated Articles
Published: October 8th 2024 | Updated: October 10th 2024
FDA Grants Survodutide Breakthrough Therapy Designation for Treatment of Adults With MASH
Published: May 19th 2023 | Updated: October 10th 2024
Bulevirtide Shows Promise for Hepatitis D, Despite No FDA Approval
Published: July 20th 2023 | Updated: October 10th 2024
Medical Gaslighting and C Diff: Understanding the Patient Experience
Published: October 1st 2024 | Updated: October 10th 2024
Celebrate American Pharmacist Month
Published: November 13th 2012 | Updated: October 10th 2024
Budget Impact of Everolimus in Treating Metastatic Renal Cell Carcinoma
Published: October 7th 2024 | Updated: October 10th 2024
Expert: Helping Fulfill Patients’ Needs Is the Most Rewarding Part of Pharmacy
